Cabaletta Bio
CABA
CABA
84 hedge funds and large institutions have $470M invested in Cabaletta Bio in 2023 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
+13
Holders Change %
+18.31%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
29
Increased
29
Reduced
13
Closed
16
Calls
$1.43M
Puts
$529K
Net Calls
+$904K
Net Calls Change
+$224K
Top Buyers
| 1 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$25.8M |
| 2 |
DM
Deerfield Management
New York
|
$30.2M |
| 3 |
BlackRock
New York
|
$22.1M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
$17.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
$11.1M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Man Group
London,
United Kingdom
| – | -$109K | – | – |
|